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Hypohidrotic and anhidrotic ectodermal dysplasia (HED/EDA) is a rare genodermatosis 
characterized by abnormal development of sweat glands, teeth and hair. Three disease causing 
genes have been hitherto identified, namely i) EDA1 accounting for X-linked forms, ii) EDAR, 
and iii) EDARADD, causing both autosomal dominant and recessive forms. Recently, WNT10A 
gene was identified as responsible for various autosomal recessive forms of ectodermal 
dysplasias, including onycho-odonto-dermal dysplasia (OODD) and Schöpf-Schulz-Passarge 
syndrome. We systematically studied EDA1, EDAR, EDARADD and WNT10A genes in a large 
cohort of 65 unrelated patients, of which 61 presented with HED/EDA. A total of 50 mutations 
(including 32 novel mutations) accounted for 60/65 cases in our series. These four genes 
accounted for 92 % (56/61 patients) of HED/EDA cases: i) EDA1 gene was the most common 
disease causing gene (58 % of cases), ii) WNT10A and EDAR were each responsible for 16 % of 
cases. Moreover, a novel disease locus for dominant HED/EDA mapped to chromosome 14q12-
q13.1. While no clinical differences between patients carrying EDA1, EDAR or EDARADD 
mutations could be identified, patients harboring WNT10A mutations displayed distinctive 
clinical features (marked dental phenotype, no facial dysmorphism), helping to decide which 
gene should be first investigated in HED/EDA. 
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Ectodermal dysplasia (ED) is a clinically and genetically heterogeneous condition characterized 
by abnormal development of two or more of the following ectodermal-derived structures: hair, 
teeth, nails, and sweat glands [Freire-Maia, 1977; Lamartine, 2003; Visinoni, et al., 2009]. 
Anomalies in other organs and systems may also be observed [Pinheiro and Freire-Maia, 1994; 
Dhanrajani and Jiffry, 1998; Priolo, et al., 2000]. Anhidrotic or hypohidrotic ectodermal 
dysplasia (HED/EDA), the most common phenotype of ED, is characterized by a triad of signs 
comprising sparse hair (hypotrichosis), abnormal or missing teeth (anodontia or hypodontia) and 
inability to sweat (anhidrosis or hypohidrosis). Typical clinical manifestations also include 
dryness of the skin, eyes, airways and mucous membranes presumably due to the defective 
development of several exocrine glands. HED/EDA can be associated with dysmorphic features 
(forehead bumps, rings under the eyes, everted nose and prominent lips) and occasionally with 
absent nipples.  
The most frequent form of HED/EDA (MIM305100) results from mutations in the EDA1 gene, 
located on chromosome Xq12-q13.1 and encoding ectodysplasin (MIM300451), a member of the 
Tumor Necrosis Factor (TNF) family [Kere, et al., 1996; Bayes, et al., 1998]. Mutations in the 
EDA receptor encoding gene EDAR, located on chromosome 2q11-q13 (MIM604095), or in the 
EDAR-Associated Death Domain encoding gene EDARADD, located on chromosome 1q42-q43 
(MIM606603), have been shown to cause autosomal recessive and dominant HED forms 
respectively [Monreal, et al., 1999; Headon, et al., 2001; Bal, et al., 2007]. These three forms are 
clinically indistinguishable, probably because they alter a single signal transduction pathway. 
Indeed, the binding of ectodysplasin to its receptor EDAR, allows the recruitment of EDARADD 
as an adapter to activate the NF-κB signalling pathway [Yan, et al., 2000; Koppinen, et al., 2001; 
Kumar, et al., 2001]. This pathway is necessary for initiation, formation and differentiation of 
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skin appendages [Mikkola, et al., 1999; Laurikkala, et al., 2002; Mustonen, et al., 2004; Mou, et 
al., 2006; Schmidt-Ullrich, et al., 2006; Pummila, et al., 2007]. 
On the other hand, loss-of-function and missense mutations in the WNT10A gene (chromosome 
2q35, MIM257980) have been shown to cause odonto-onycho-dermal dysplasia, a rare form of 
ectodermal dysplasia [Adaimy, et al., 2007; Nawaz, et al., 2009]. Subsequently, WNT10A 
mutations have been reported in various forms of ectodermal dysplasia, including in three 
patients with sweating anomalies [Bohring, et al., 2009; Nagy, et al., 2010; van Geel, et al., 
2010]. 
In order to evaluate the impact of EDA1, EDAR, EDARADD and WNT10A mutations in 
HED/EDA, we have sequenced all four genes in a large cohort of 65 unrelated patients. Among 
them, 61 patients had HED/EDA. Our study shows that only four genes account for more than 90 
% of cases in HED/EDA. 
 
Patients and Methods 
Patients 
Since 2002, a total of 65 patients were recruited by the departments of Dermatology and Genetics 
of Necker-Enfants Malades Hospital. Patients included in this study presented abnormalities of at 
least two of the three following ectodermal structures: teeth, hair and sweat glands. Most of those 
patients (53/65) presented the classical triad of HED/EDA phenotype. The relatives of the 
probands occasionally presented abnormalities of only one epidermal structure. The great 
majority of cases were familial cases (48/65) of Caucasian origin (45/65). A total of 9/65 patients 
were born to related parents. Informed consent for DNA analysis and reproduction of the 
photographs was obtained from all individuals concerned. 
Mutation detection 
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DNA was extracted from patients’ blood leukocytes using the Illustra DNA extraction kit 
BACC3 (GE Healthcare), following manufacturer’s instructions. All exons and at least 60 base 
pair of flanking intronic sequences of the EDA1 (NM_001399.4), EDAR (NM_022336.3), 
EDARADD (NM_080738.3) and WNT10A genes (NM_025216.2) were amplified by PCR using 
specific primers (see Supp. Table S1). Both DNA strands were sequenced using the Big DyeTM 
Terminator Cycle Sequencing Ready Reaction Kit version 3.1 (Applied Biosystems). Sequence 
variations were numbered with +1 corresponding to the A of the ATG translation initiation codon 
in the cDNA reference sequence, or with the initiation codon as codon 1 in the proteic reference 
sequence, according to journal guidelines (www.hgvs.org/mutnomen). 
For Quantitative Multiplex PCR of Short fluorescent Fragments analysis (QMPSF), exon 18 of 
MLH1 gene (E. coli MutL Homolog 1) or exon 3 of GFAP gene (Glial Fibrillary Acidic Protein) 
were amplified as positive controls, along with each exon of the WNT10A gene (see Supp. Table 
S1). PCR products were migrated using an ABI3130 sequencer (Applied Biosystems), and 
analyzed with GeneScan Analysis software version 3.7 (Applied Biosystems). 
A genome-wide scan for one large family carrying no known mutation was undertaken with 382 
pairs of fluorescent oligonucleotides of the Genscan Linkage Mapping set, version II (average 
spacing of 10 cM, Perkin-Elmer Cetus) under conditions recommended by the manufacturer. To 
refine the novel HED locus identified, additional microsatellites DNA markers from chromosome 
14q region were studied. After amplification, PCR products were pooled with GeneScan 400D 
ROX size standard ladder (0.3 µl; Applied Biosystems), and analyzed on an ABI3130 sequencer. 
 
Results 
A total of 31 EDA1 mutations, including 20 novel mutations were identified in 35/65 cases of our 
cohort (Table 1, Figure 1A, Supp. Figure S1A). Most of those mutations were missense 
mutations (24/31), located in exons 3 and 5 to 9. The male patients carrying EDA1 mutations 
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were severely affected, as they all displayed anomalies in the three ectodermal structures. Carrier 
females were occasionally moderately affected, but two displayed unusually severe symptoms 
(patients EDA1-F19 and EDA1-F24, Figure 1B1-2).  
As to the EDAR gene, a total of 10 mutations, including 5 novel mutations, were identified in 
10/65 patients (Table 1, Figure 1A, Supp. Figure S1B). Five mutations were dominantly, and five 
recessively inherited. They were mostly located in exons 9 to 12 (7/10). 
Interestingly, the dominant mutations were all located close to the EDAR Death Domain (DD, 
two missense mutations, one single residue duplication and two frameshift mutations). 
Clinical features of these patients were indistinguishable from those observed in EDA1 patients. 
However, individuals carrying dominant EDAR mutations were less severely affected than their 
recessive counterparts (Figure 1C and D). This was particularly true with respect to sweating 
(Table 1). 
As to the EDARADD gene, only one novel dominantly inherited missense mutation was found in 
a patient with a moderate HED phenotype (NM_080738.3: c.328G>T, p.D110Y; Table 1, Figure 
1E1-2). This mutation located near the EDARADD Death Domain (Supp. Figure S1C), probably 
altered its interaction with EDAR and/or multimerization of EDARADD.  
As to the WNT10A gene, a total of 8 mutations were identified in 14/65 cases (9 familial and 5 
sporadic cases; Table 2, Figure 2, and Supp. Figure S1D). They included 5 novel missense 
mutations and the first WNT10A duplication identified to date. The p.F228I mutation was 
prevalent in our cohort (10/14 patients) and found in homozygote or compound heterozygote 
patients. None of those mutations were found in 150 control chromosomes from healthy 
Caucasian individuals. QMPSF analysis of the four exons of the WNT10A gene in six 
heterozygote patients failed to detect any intragenic deletion (not shown). 
Interestingly, most patients carrying WNT10A mutations (10/14) presented with sweating 
anomalies, including total anhidrosis for two of them (WNT10A-F03 and S01). However, 
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comparison of those patients with HED/EDA cases harboring mutations in the ectodysplasin 
pathway allowed us to identify slight differences in their respective phenotypes.  Indeed, 
dermatological features (anomalies of hair and sweat glands) were less severe and none of the 
patients carrying WNT10A mutations presented facial dysmorphism. Their dental phenotype 
consisted in microdontia, while teeth agenesis was more frequent in patients carrying mutations 
in the ectodysplasin pathway (Table 2, Figure 1F1-3 and 1G). The other four patients with 
WNT10A mutations presented with incomplete form of OODD or unclassified form of ED (Table 
2). 
Finally, among the 5/65 unexplained cases of our cohort, one patient was the proband of a four-
generation French family, presenting an autosomal dominant HED (patient HED-F01, Supp. 
Table S2). Genome-wide scan analysis led to the mapping of this novel disease gene to a 5 cM 
interval on chromosome 14q12-q13.1 (Zmax = 4.8; Supp. Figure S3). The strongest candidate 
genes have been excluded by sequencing analysis (PAX9, NFKBIA, PSMA6, SNX6, MBIP). None 
of the remaining known genes mapping to this region were involved in either ectodysplasin or 
Wnt signalling pathways. 
 
Discussion 
Here we show that four genes (EDA1, EDAR, EDARADD and WNT10A) accounted for 92 % of 
cases in a series of 65 unrelated patients, of which 61 presented with HED/EDA. EDA1 mutations 
were prevalent (58 % of cases). WNT10A mutations were more frequent than EDAR mutations in 
our cohort, but both genes are each responsible for 16 % of HED/EDA cases (Figure 1A).. We 
also report here on a novel disease gene mapping to chromosome 14q12-q13.1 and accounting for 
autosomal dominant HED/EDA.  
The phenotypes associated with EDA1, EDAR, and EDARADD mutations were indistinguishable 
and consistently included hypohidrosis or anhidrosis, sparse hair, and oligodontia with abnormal 
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conical teeth, frequently associated with dryness of skin, eczema and facial dysmorphism. Yet, 
the clinical expression of WNT10A mutations was highly variable. WNT10A gene was first 
involved in OODD syndrome (MIM257980) and subsequently in Schöpf-Schulz-Passarge 
syndrome (MIM224750) [Adaimy, et al., 2007; Bohring, et al., 2009]. We confirmed the 
involvement of WNT10A gene in OODD or OODD-like forms of ED (3/14 patients), and 
unclassified ED (1/14; Table 2). Moreover, 10/14 patients of our cohort harboring WNT10A 
mutations presented with anomalies corresponding to HED/EDA, ie hypohidrosis or anhidrosis 
associated with teeth and hair anomalies. Thus our results expanded the spectrum of WNT10A 
mutations to HED/EDA phenotype. The variability of phenotypes associated to WNT10A 
mutations is not understood yet. The type of mutations (nonsense or missense) and their 
functional effects could explain this broad spectrum of phenotypes.  
Our study gives support to the high incidence of EDA1 mutations (35/61, 58 %), and the scarcity 
of EDAR mutations in HED/EDA (10/61, 16 %) [Vincent, et al., 2001; Chassaing, et al., 2006; 
van der Hout, et al., 2008]. Interestingly, while WNT10A was reportedly known to account for 
various forms of ED, we provide here the first evidence for its very high incidence in HED/EDA 
cases (10/61, 16 %) [Adaimy, et al., 2007; Bohring, et al., 2009; Nawaz, et al., 2009; Nagy, et al., 
2010]. 
Yet, the mode of inheritance of WNT10A mutations remains unclear. While eight patients were 
homozygotes or compound heterozygotes, only one heterozygous mutation was identified in six 
patients. Although a single mutation could probably explain the moderate cases (WNT10A-F08, 
–F09 and –S04), the three severely affected patients may carry a second un dentified mutation (in 
intronic or regulatory sequences of WNT10A). Alternatively, a dominant mode of inheritance with 
variable penetrance could also explain the severe phenotype of these patients. 
A higher proportion of tooth anomalies has been previously described in males harboring 
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not found in our cohort. Dental abnormalities were the most frequent manifestation in 
heterozygous patients in both sexes. This difference may result from the high frequency of the 
p.C107X mutation in the German/Turkish cohort [Bohring, et al., 2009]. 
Most of the HED mutations reported here were missense mutations, located in functionally 
important domains of the protein (furin clivage site, collageneous and TNF domains for 
Ectodysplasin; Death Domain for EDAR and EDARADD). Interestingly, all dominant mutations 
reported to date in EDAR were located in its C-terminal region near its Death Domain. These 
mutations probably exert a dominant negative effect on the wild-type allele via the formation of 
non-functional multimers, unable to recruit EDARADD. All missense EDARADD mutations are 
located in (or very close to) the Death Domain of EDARADD, probably impairing its interaction 
with EDAR.  
The involvement of the ectodysplasin/NF-κB and Wnt/β-catenin pathways in ectodermal 
appendage development has long been known [Kere, et al., 1996; Gat, et al., 1998]. Because the 
two pathways are involved in early steps of ectodermal placode development, one can 
hypothesize that the 10 % hitherto unknown mutations may lie in either of these two pathways. 
In conclusion, WNT10A gene should be considered as a candidate gene for HED/EDA, especially 
in the clinical condition of microdontia, sweating anomalies, and absence of facial dysmorphism. 
Alternatively, patients with the classical triad of HED/EDA signs and facial dysmorphism, should 
be first studied for EDA1 gene, except in non-X-linked familial cases. If no mutation is identified 
in EDA1, EDAR is the next gene to consider, before WNT10A and EDARADD. 
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Legends to figures 
 
Figure 1: Mutation distribution and clinical appearance of HED/EDA patients.  
A: Frequencies of identified mutations for each known gene in our series of 61 HED/EDA 
patients. B1-B4: severely affected female patient (EDA1-F19) at age 6 years (B1, B2) and her 
brother at age 5 years (B3, B4). C: severely affected patient EDAR-F01 at age 3 years. D: 
moderately affected patient EDAR-F05 at age 30 years. E1-E2: EDARADD-F01 at age 9 years. 
F1-F3: WNT10A-F03 at age 16 years. G: WNT10A-S04 at age 5 years. Pictures collection from 
the department of Dermatology, Necker-Enfants Malades Hospital, Paris. 
 
Figure 2: Pedigrees of the 9 families carrying mutations in WNT10A gene.  
Mutations identified in each individual are indicated, WT designated a second wild-type allele. 
Filled symbols represented severely affected individuals, half-filled symbols moderately affected 
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origin Hair Teeth Sweating Other signs Nucleotide changes 
Predicted proteic 
changes 
EDA1 (previously described mutations) 
EDA1-F01 M, 10 Martinique ++ ++ ++ Eczema 
c.466C>T 
(Bayes et al., 1998; Monreal 
et al., 1998) 
p.R156C 
EDA1-F02 M, 5 Algeria, CS ++ +++ ++ Eczema, dry skin, facial dysmorphism 
c.467G>A 
(Monreal et al., 1998) p.R156H 
EDA1-F03 M, 5 Tunisia ++ +++ +++ Eczema, dry skin c.730C>T (Vincent et al., 2001) p.R244X 
EDA1-F04 F, 4 France + + (C) ++ Dry skin, facial dysmorphism 
c.764G>A 
(Pääkkönen et al., 2001) p.G255D 
EDA1-F05 M, 8 France +++ ++ +++ Facial dysmorphim c.871G>C (Bayes et al., 1998) p.G291R 
EDA1-F06 M, 14 France ++ +++ +++ Eczema, facial dysmorphism c.871G>A (Bayes et al., 1998) p.G291R 
EDA1-S01 M, 16 Spo, Yemen and Djibouti +++ +++ ++ Facial dysmorphism 
c.871G>A 
(Bayes et al., 1998) p.G291R 
EDA1-F07 M, 28 France ++ ++ +  c.871G>A (Bayes et al., 1998) p.G291R 
EDA1-F08 M, 13 France + +++ ++ Dry skin, eczema, facial dysmorphism 
c.892G>C 
(Bayes et al., 1998) p.D298H 
EDA1-S02 M, 4 Spo, Morroco, CS + +++ ++ Nipples hypoplasia c.895G>A (Monreal et al., 1998) p.G299S 
EDA1-F09 F, 28 France ++ ++ + Hypoplasia of the right 
nipple 
c.895G>A 
(Monreal et al., 1998) p.G299S 
EDA1-F10 M, 3 France + +++ ++ Eczema c.1133C>T (Vincent et al., 2001) p.T378M 
EDA1-F11 M, 8 France ++ +++ ++ Eczema c.1141G>A (Gunadi et al. 2009, G>C) p.G381R 
         
EDA1-F12 M, 36 France +++ +++ +++ Dry skin c.789_825del (Bayes et al., 1998) p.K263DfsX5 
         
EDA1-F13 M, 10 France + ++ + Eczema 
c.-181?_396+?del 
(Kere et al., 1996 ; 
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origin Hair Teeth Sweating Other signs Nucleotide changes 
Predicted proteic 
changes 
EDA1 (novel mutations) 
EDA1-F14 F, 29 Algeria +++ ++ - Eczema c.2T>G p.M1R 
EDA1-F15 M, 31 France ++ +++ ++  c.358G>T p.E120X 
EDA1-F16 F, 6 France + ++ - Dry skin, eczema c.466C>G p.R156G 
EDA1-F17 M, 3 France ++ +++ +++  c.620G>T p.G207V 
EDA1-F18 M, 5 France ++ + (C) + Dry mouth, facial dysmorphism c.632C>G p.T211R 
EDA1-S03 M, 9 Spo, France/India +++ +++ ++ 
Eczema, facial 
dysmorphism c.694C>T p.Q232X 
EDA1-F19 F, 10 France ++ ++ +  c.797T>G p.L266R 
EDA1-F20 M, 14 France + +++ + Dry skin, eczema c.820T>A p.W274R 
EDA1-S04 M, 2 Spo, Congo +++ +++ +++  c.878T>C p.L293P 
EDA1-F21 M, 6 France + ++ - Eczema c.886C>G p.L296V 
EDA1-S05 M, 11 Spo, France ++ +++ ++  c.896G>A p.G299D 
EDA1-S06 M, 33 Spo, France ++ +++ + Palmar keratoderma, facial dysmorphism c.968T>G p.V323G 
EDA1-S07 M, 16 Spo, France +++ +++ ++ Dry skin, eczema c.1037G>A p.C346Y 
EDA1-S08 M, 6 Spo, France + + +  c.1067C>T p.A356V 
         
EDA1-F22 M, 34 France +++ +++ +++  c.397-1G>A p.? 
EDA1-F23 M, 6 Japan ++ +++ ++ Dry skin, facial dysmorphism c.925-1G>C p.? 
         
EDA1-F24 F, 43 France ++ ++ ++  c.361delG p.A121PfsX16 
EDA1-F25 M, 3 Japan + +++ ++ Eczema, no lacrimation c.640dupA p.M214NfsX26 
EDA1-F26 M, 5 France + +++ + Eczema c.573_590del p.G192_Q197del 
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Proband’s number Sex, age (year) 
Transmission, 




EDAR-S01 M, 7 Spo, AR, Portugal ++ +++ ++ Eczema 
c.[266G>A]+[442+1G>A] 
(Monreal et al. 1999; Chassaing et 
al. 2006) 
p.R89H + ? 
EDAR-F01 M, 3 AR, Pakistan, CS + +++ ++  c.[1073G>A]+[1073G>A] (Shimomura et al., 2009) 
p.R358Q + 
p.R358Q 
EDAR-F02 M, 11 AR, Kuwait, CS ++ ++ ++  c.[1208C>T]+[1208C>T] (Chassaing et al. 2006) 
p.T403M + 
p.T403M 
EDAR-F03 F, 8 AD, France ++ ++ + Facial dysmorphism c.1222A>T p.I408F 
EDAR-F04 M, 17 AD, Sefarad + + + Facial dysmorphism c.1259G>A (Monreal et al. 1999) p.R420Q 
EDAR-F05 M, 34 AD, Algeria, CS ++ + + Dry skin c.1259G>A (Monreal et al. 1999) p.R420Q 
         
EDAR-S02 M, 3 Spo, AR, Turkey, CS +++ +++ +++ 




EDAR-S03 F, 37 Spo, AD, Portugal + ++ +  c.875_876del p.P292RfsX52 
EDAR-F06 F, 10 AD, Sefarad ++ +++ + Eczema, dry skin c.1049_1052del p.D351AfsX20 
EDAR-F07 M, 6 AD, Portugal, CS + + +  c.1186_1188dup p.Q396dup 
EDARADD 
EDARADD-F01 F, 11 AD, France + + + Dry skin, abnormal nails, palmo-plantar keratoderma c.328G>T p.D110Y 
Mutations are annotated with +1 corresponding to the A of the ATG translation initiation codon, or with the initiation codon as codon 1 in the GenBank reference sequences 
(NM_001399.4, and NP_001390.1 for EDA1; NM_022336.3, and NP_071731.1 for EDAR; NM_080738.3 and NP_080738.3 for EDARADD). For the three genes: M male; F 
female; Spo sporadic (all other cases are familial), CS consanguinity, AR autosomal recessive, AD autosomal dominant; +, ++, and +++ degree of severity of present feature, 
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Teeth Sweating Other signs Nucleic changes Predicted proteic 
changes 
HED/EDA phenotype 
II.1 M, 46 France - - -  c.682T>A p.F228I 
II.3 F, 44 France - A -  c.321C>A p.C107X WNT10A-F01 
III.1 M, 17 France - A+ Hypo  c.[321C>A]+[682T>A] p.C107X + p.F228I 
I.1 F, 70 France - A Hypo  c.[682T>A](+)[682T>A] p.F228I + p.F228I 
II.1 M, 49 France - D -  c.682T>A p.F228I 
II.2 F, 45 France - - -  c.321C>A p.C107X 
II.3 M, 46 France - - -  c.321C>A p.C107X 
II.4 F, 44 France - Ed Hyper  c.682T>A p.F228I 
II.5 F, 46 France - Ed, Sh Hyper Dry skin c.682T>A p.F228I 
II.6 M, 50 France - - -  c.321C>A p.C107X 
III.1 M, 18 France - A - Palmo-plantar keratoderma c.[321C>A]+[682T>A] p.C107X + p.F228I 
III.4 F, 16 France - A -  c.[321C>A]+[682T>A] p.C107X + p.F228I 
WNT10A-F02  
III.5 M, 24 France - A, D -  c.[321C>A]+[682T>A] p.C107X + p.F228I 
I.2 F, 63 France - D Hypo  c.[321C>A]+[347T>C] p.C107X + p.I116T 
II.2 F, 41 France - D Hypo  c.321C>A p.C107X 
III.1 M, 18 France T A+ Anh Dry eyes, otitis c.[321C>A]+[682T>A] p.C107X + p.F228I WNT10A-F03 
III.2 M, 14 France - - -  c.321C>A p.C107X 
II.3 M, 44 France Eb A Hypo  c.682T>A p.F228I WNT10A-F07 II.4 M, 44 France Eb A Hypo  c.682T>A p.F228I 
I.1 M, 42 France - C, Ed -  c.682T>A p.F228I WNT10A-F08  II.2 F, 13 France T A Ih  c.682T>A p.F228I 
I.2 M, 77 France - - Ih  c.682T>A p.F228I 
II.2 F, 42 France - - -  c.682T>A p.F228I 
III.1 F, 16 France - M, A+ -  c.682T>A p.F228I 






III.3 F, 9 France - M, A+ -  c.682T>A p.F228I 
WNT10A-S01 F, 29 Turkey, CS T M, A Anh Follicular keratosis c.[433G>A](+)[433G>A] p.V145M + p.V145M 
WNT10A-S02 F, 18 China, CS T M, A Hypo Palmoplantar keratoderma c.[742C>T](+)[742C>T] p.R248X + p.R248X 
WNT10A-S03 F, 9 France Eb M, A Hyperthermia 
upon infections Dry skin c.427C>T p.H143Y 
WNT10A-S04 M, 6 France T M, A, Sh Hypo  c.682T>A p.F228I 
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Teeth Sweating Other signs Nucleic changes Predicted proteic 
changes 
OODD syndrome 







I.2 M, 89 France Sp ? ? Thick nails c.682T>A p.F228I 
II.1 F, 57 France ? ? ?  c.682T>A p.F228I 
II.2 M, 48 France - S -  c.682T>A p.F228I WNT10A-F04 
III.2 F, 24 France - M,A+, C, D - Split nails, eczema c.[682T>A]+[682T>A] p.F228I + p.F228I 
I.2 F, 66 France - - -  c.682T>A p.F228I 
I.6 F, 58 France - Ed -  c.682T>A p.F228I 
II.1 F, 29 France - PT -  c.682T>A p.F228I WNT10A-F05 
II.2 F, 25 France T M,A+ - Nail dystrophy c.[682T>A](+)[682T>A] p.F228I + p.F228I 
Unclassified ED 
I.1 F, 50 France T - - Eczema c.1078C>T p.R360C 
I.2 M, 47 France - Ed Hyperhidrosis Delayed puberty c.682T>A p.F228I 
II.1 F, 20 France T A -  c.[682T>A]+[1078C>T] p.F228I + p.R360C 
II.2 M, 17 France T A+, Ed 
Hyperhidrosis 
upon infections 
Soft nails, eczema, 





p.F228I + p.R360C WNT10A-F06 
II.3 M, 13 France - A- Hyperhidrosis 
upon infections Eczema c.[682T>A]+[1078C>T] p.F228I + p.R360C 
Mutations are annotated with +1 corresponding to the A of the ATG translation initiation codon, or with the initiation codon as codon 1 in the GenBank reference sequences 
(NM_025216.2, and NP_079492.2 for WNT10A). Probands (in bold) and their relatives figure in the table, all numbered from their pedigree presented in Figure 2. M male; F 
female; WNT10A-F01 to F09 are familial cases, WNT10A-S01 to S05 are sporadic; CS consanguinity; - within normal clinical limits, ? unknown information; A agenesis, 
A+ severe agenesis, M microdontia, Ed enamel dysplasia, D persistant decidual teeth, C conical teeth, Sh abnormal tooth shape, PT palatal tooth; T thin and fragile hair, Eb 
rare eyebrows, Sp sparse hair; Ih intolerance to heat, Hypo hypohidrosis and Anh anhidrosis. 
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Supp. Figure S1: Distribution of previously known and newly identified mutations regarding to functional domains of EDA1 (A), EDAR (B), EDARADD (C) and WNT10A 
proteins (D). Missense mutations are indicated above the schematic representation of each protein, whereas nonsense, splice and truncating mutations are positioned 
underneath. Mutations with a dominant mode of inheritance in EDAR and EDARADD figure in blue; newly identified mutations are underlined in red. Ectodysplasin is 
mainly mutated in its furin cleavage site, its collageneous and its TNF domains. Mutations in EDAR are located either in the N-terminal ligand binding domain, or in the C-
terminal Death Domain (DD). Interestingly, all dominant EDAR mutations are located in its C-terminal region. All EDARADD missense mutations are located in or very 
close to its Death Domain. TM: transmembraneous domain; F: furin cleavage site; COLL: collagen domain; TNF: TNF-like domain; PS: peptide signal; TNFR1 to -3: TNF 
Receptor like domain; DD: Death domain. Reference sequences used to annotate all mutations are: NP_001390.1 (EDA1), NP_071731.1 (EDAR), NP_080738.3 
(EDARADD), NP_079492.2 (WNT10A). 
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Supp. Figure S2: Evolutionary conservation of residues with novel missense mutations in EDA1, EDAR, EDARADD and WNT10A proteins. 
Alignments were perfoemd using Clustalw program, using a BLOSUM matrix. 
(A) Conservation of the 10 novel missense mutations in EDA1: sequences used for the alignment are NP_001390.1 (Homo sapiens), XP_529025.2 (Pan troglodytes), 
XP_001082424.1 (Macaca mulatta), NP_034229.1 (Mus musculus), XP_228582.5 (Rattus norvegicus), NP_001075212.1 (Bos taurus), NP_001014770.1 (Canis lupus 
familiaris), XP_420158.1 (Gallus gallus), NP_001108537.1 (Danio rerio). 
(B) Conservation of the novel missense mutation on residue I408 in EDAR: sequences used for the alignment are NP_071731.1 (Homo sapiens), XP_001139583.1 (Pan 
troglodytes), XP_001084259.1 (Macaca mulatta), NP_034230.1 (Mus musculus), XP_345110.4 (Rattus norvegicus), XP_538426.2 (Canis familiaris), NP_001012629.1 
(Gallus gallus), NP_001080516.1 (Xenopus laevis), NP_001108536.1 (Danio rerio). 
(C) Conservation of the novel missense mutation on residue D110 in EDARADD: sequences used for the alignment are NP_542776.1 (Homo sapiens), XP_514291.2 (Pan 
troglodytes), XP_001099801.1 (Macaca mulatta), NP_598398.3 (Mus musculus), XP_574055.3 (Rattus norvegicus), XP_596273.2 (Bos taurus), XP_849101.1 (Canis 
familiaris), NP_001012405.2 (Gallus gallus), XP_695138.3 (Danio rerio). 
(D) Conservation of the four novel missense mutations in WNT10A: sequences used for the alignment are NP_079492.2 (Homo sapiens), XP_516098.2 (Pan troglodytes), 
XP_001095740.1 (Macaca mulatta), NP_033544.1 (Mus musculus), NP_001101697.1 (Rattus norvegicus), NP_001092548.1 (Bos taurus), XP_545648.2 (Canis familiaris), 
NP_001006590.1 (Gallus gallus), ABG49498.1 (Xenopus laevis), NP_571055.1 (Danio rerio), NP_609109.2 (Drosophila melanogaster). 
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Supp. Figure S3: Haplotype analysis of the HED family for polymorphic markers on chromosome 14q12-13.1. Four recombinant events occurred in individuals III.19, IV.2, 
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Supp. Table S1: Sequences of the primers used for direct sequencing of EDA1, EDAR, EDARADD 
and WNT10A genes, and QMPSF analysis for WNT10A gene. 
Genes Exons Forward primers (5’-3’) Reverse primers (5’-3’) 
1 CGGAGTAGAGCTGCACATGCG CCAGGGCAGGTTGTCTTCGGT 
3 GGAGGGGAAGATGGGCTCAG TGGTGGCTCACGCCTGTAAT 
4 AGGAGTCAGAAGACAGAATGG AAGGGCAGGGAGAAGAACAAG 
5 AGATCGTGCCACTGAACTCC GCTCTCAGGATCACCCACTC 
6 CCACTGAAGATGAAGGTCAGG GCAAGACACCCTTTCCTTAGC 
7 GGTCACATAGCTAGGAAGCGG CTTTCAGCTCCGTCATCAGTG 
8 CAGGCCTGGCAGCTGCTTTAC TGGCCCCCTCTCTCTTTCCTC 
EDA1 
9 GAACAATGCCTGTCACCTGTC AAGTCAAGCAGGCCTTGTCAC 
2 CAGAGTCAGCCCAAGTGGCAT GCTGTGTGTATCACACCACAAAC 
3 CCAGGTGATCAACCAGGAGCC ATGAATGCTTAGCTGGTGAGTGC 
4 AGACAGCTGGCACGTCACT ACAGGGGTCATGGATACTGC 
5 CTGAGTGGACAGAGCAGGTG AAGGCTCAGATGTGGCAAAC 
6 CAATAACGATGACTCTTTAGGG GAGTTGATCCCTCTATGGGTG 
7-8 CCAGCGCGGAGGATTTGGTTC CAGTATGGTTCAGCATGTGAGAG 
9 TGCTTGTGCTCTCACATGCT CCAGTCAGCAAAGAGGTGGT 
10 GTGCCCACAAGGTGCCCAGT CCCGTCTTGCAGGAGAGCTGA 
11 AGTCTGACCACCCAGCTGAGC ATGCCTTCCGATATCTGGGAAC 
EDAR 
12 CCTTCTATTGACTGTGACTTGCAACA AGCTCCAGAGCCCTCGTTGG 
1a GAAAGAACCACAAACCAAACC TGCCTTCACACATAAGAACAG 
1b AGGTACCGAGGGACGCGC GTTTGCAGGACGTGTCTCAAC 
2 AGTAAGGTTTTCTTCAGCCTAAG CCAGGGAAGTGGGTAAAGCC 
3 CCTTGATTTCATTCCTGTCGA GTCACGAGCTAATCTATGGGC 
4 ATCCTTAAGAGCAGAGTTTGG CTGTTTATGATCTAGAAATCCTG 
5 GCGCTCAAGGTGCTCGTATTCT TTACAGGCGCCCACCACAACC 
6-1 TATGATGCTTTTGACAATTCAGCA ACGAGCACAATTCGTCATAGGACA 
EDARADD 
6-2 CGTGTCACCCAACGGTGAAAA CCCCTCCACAAAACTGCCAGC 
1 GAGTCGGAGCTGTGTGTCG GAGCTCACTGCCTTTGGTTC 
2 CTGGGCAGGATGATTGTGAG CTGAGATCAGAAAGAGGAAGG 
3 TGATTTCTGCCCTTCTTTGAC TGCACAGTGCATACTCAGTG WNT10A 
4 GGTACAGAAGTTCTTCTGACTG AGAAGTGAGTGGTGGGGTTC 
1 GAGTCGGAGCTGTGTGTCG FAM-AGCGCTGGCCGCGGCTGG 
2 FAM-CTATGAGAGTCCCATCTTCAGC CTGAGATCAGAAAGAGGAAGG 
3 TGATTTCTGCCCTTCTTTGAC FAM-CGATGGCGTAGGCAAAAGCG 
WNT10A-
QMPSF 
4 GGTACAGAAGTTCTTCTGACTG FAM-CCACGAAACAGCACCAGTGG 
GFAP-
QMPSF 3 GAGGAAAGGATTGATGGCCA FAM-AAGAACCGGATCTCCTCCTC 
MLH1-
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age (year) Ethnical origin Hair Teeth Sweating Other signs 
HED-F01 F, 18 France ++ +++ +++ Onychodystrophy 
HED-F02 M, 11 Portugal ++ + +++ Facial dysmorphism 
HED-F03 M, 19 France +++ ++ +++ Telangiectasia on the face 
HED-S01 M, 10 Spo, France - +++ ++  
HED-F04 M, 10 France ++ ++ ++  
M male; F female; Spo sporadic (all other cases are familial); +, ++, and +++ degree of severity of present feature, - 
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